BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24562604)

  • 1. Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes.
    Côrte-Real L; Mendes F; Coimbra J; Morais TS; Tomaz AI; Valente A; Garcia MH; Santos I; Bicho M; Marques F
    J Biol Inorg Chem; 2014 Aug; 19(6):853-67. PubMed ID: 24562604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
    Sanz Del Olmo N; Bajo AM; Ionov M; García-Gallego S; Bryszewska M; Gómez R; Ortega P; de la Mata FJ
    Eur J Med Chem; 2020 Aug; 199():112414. PubMed ID: 32438200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
    Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
    Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
    Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
    Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
    Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
    Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
    Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells.
    Ballester FJ; Ortega E; Porto V; Kostrhunova H; Davila-Ferreira N; Bautista D; Brabec V; Domínguez F; Santana MD; Ruiz J
    Chem Commun (Camb); 2019 Jan; 55(8):1140-1143. PubMed ID: 30631876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
    Selvamurugan S; Ramachandran R; Viswanathamurthi P
    Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
    Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
    Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs.
    Moreira T; Francisco R; Comsa E; Duban-Deweer S; Labas V; Teixeira-Gomes AP; Combes-Soia L; Marques F; Matos A; Favrelle A; Rousseau C; Zinck P; Falson P; Garcia MH; Preto A; Valente A
    Eur J Med Chem; 2019 Apr; 168():373-384. PubMed ID: 30826512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
    Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular localization and transport kinetics of ruthenium organometallic anticancer compounds in living cells: a dose-dependent role for amino acid and iron transporters.
    Klajner M; Licona C; Fetzer L; Hebraud P; Mellitzer G; Pfeffer M; Harlepp S; Gaiddon C
    Inorg Chem; 2014 May; 53(10):5150-8. PubMed ID: 24786362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
    Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
    Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
    Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
    Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.